OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Pawlik on Advances in Management of mCRC With Liver Metastases

December 9th 2020

Timothy M. Pawlik, MD, PhD, MPH, discusses advances in the management of patients with metastatic colorectal cancer with liver metastases.

Dr. Rampal on the Evolution of Prognostic Models in Essential Thrombocythemia

December 8th 2020

Raajit K. Rampal, MD, PhD, discusses the evolution of prognostic models in essential thrombocythemia.

Dr. Tawbi on Future Research Efforts in Melanoma

December 8th 2020

Hussein A. Tawbi, MD, PhD, discusses future research efforts in melanoma.

Dr. Kahl on Remaining Challenges With CAR T-Cell Therapy in DLBCL

December 8th 2020

Brad S. Kahl, MD, discusses remaining challenges with CAR T-cell therapy in diffuse large B-cell lymphoma.

Dr. Matulonis on the Need to Improve Immunotherapy Responses in Gynecologic Cancers

December 8th 2020

Ursula A. Matulonis, MD, discusses the need to improve responses to immunotherapy among patients with recurrent gynecologic cancers.

Dr. Lin on Updated Results of the CRB-401 Trial in Relapsed/Refractory Multiple Myeloma

December 8th 2020

Yi Lin, MD, PhD, discussess updated results of the phase 1 CRB-401 study in relapsed/refractory multiple myeloma.

Dr. Zeiser on Results of the REACH3 Trial in Chronic GVHD

December 8th 2020

Robert Zeiser, MD, discusses results of the REACH3 trial in chronic graft-versus-host disease.

Dr. Hill on the Safety Profiles of BTK Inhibitors in MCL

December 7th 2020

Brian T. Hill, MD, PhD, discusses the safety profiles of BTK inhibitors in mantle cell lymphoma.

Dr. Schweizer on the Role of Olaparib in Non–BRCA-Mutant mCRPC

December 7th 2020

Michael Schweizer, MD, discusses the role of olaparib in patients with non–BRCA-mutant metastatic castration-resistant prostate cancer.

Dr. Buske on the Results of the iNNOVATE Trial in Waldenström Macroglobulinemia

December 7th 2020

Christian Buske, MD, discusses the results of the iNNOVATE trial in Waldenström macroglobulinemia.

Dr. Mesa on the Anticipated Utility of Momelotinib in Myelofibrosis

December 7th 2020

Ruben A. Mesa, MD, discusses the anticipated utility of momelotinib in myelofibrosis.

Dr. Jain on the Rationale to Evaluate Ibrutinib/Rituximab in MCL

December 7th 2020

Preetesh Jain, MD, PhD, discusses the rationale to evaluate ibrutinib in combination with rituximab in mantle cell lymphoma.

Dr. Voorhees on Updated Results of the GRIFFIN Trial in Multiple Myeloma

December 7th 2020

Peter Voorhees, MD, a multiple myeloma specialist at Levine Cancer Institute, of Atrium Health, discusses updated results of the GRIFFIN trial in multiple myeloma.

Dr. Cutler on the Results of the ROCKstar Study in cGVHD

December 6th 2020

Corey S. Cutler, MD, MPH, FRCPC, discusses the results of the ROCKstar study in chronic graft-versus-host disease.

Dr. Vasileiou on the Potential Role of ALVR109 for the Treatment of COVID-19

December 6th 2020

Spyridoula Vasileiou, PhD, discusses the potential role of ALVR109, a SARS-CoV-2 virus–specific T-cell therapy, for the treatment of coronavirus disease 2019.

Dr. Verstovsek on the Results of the PV-AIM trial in Polycythemia Vera

December 5th 2020

Srdan Verstovsek, MD, PhD, discusses findings from the PV-AIM trial in polycythemia vera.

Dr. Wierda on the Results of the CAPTIVATE Trial in CLL and SLL

December 5th 2020

William G. Wierda, MD, PhD, discusses results from the CAPTIVATE trial in chronic lymphocytic leukemia and small lymphocytic lymphoma.

Dr. El Chaer on the Role of Next-Generation Sequencing in MPNs

December 4th 2020

Firas El Chaer, MD, discusses the role of next-generation sequencing (NGS) in myeloproliferative neoplasms.

Dr. Seymour on Investigational BTK Inhibitors in CLL

December 4th 2020

Erlene Seymour, MD, discusses investigational BTK inhibitors in chronic lymphocytic leukemia.

Dr. Ruan on Future Research With CAR T-Cell Therapy in MCL

December 4th 2020

Jia Ruan, MD, PhD, discusses future research with CAR T-cell therapy in mantle cell lymphoma.